The Canada contraceptive devices market size is estimated to expand at a CAGR of around 7.88% over the forecast period. Rising awareness in Canadian population regarding contraception methods, investments by key players to develop innovative devices, and favorable government initiatives to improve access to products are the major factors accelerating the growth.

In addition, rising the prevalence of sexually transmitted diseases and growing need for population control fueling the regional market growth. For instance, as per the data published by Institute for Health Metrics and Evaluation, there were 5.70 million Canadian population were living with HIV/AIDS & sexually transmitted diaseses in year 2019. Thus, increasing demand for contraceptive devices to avoid additional healthcare costs is likely to aid market growth.

Moreover, initiatives by governments to raise awareness regarding contraceptives and family planning have also helped the growth of the market. However, the side effects of contraceptive devices have been restraining the studied market s growth.

Key Market Trends
Condoms are Expected to Dominate the Canada Contraceptive Devices Market
A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also to a lesser extent protect against genital herpes, human papillomavirus (HPV), and syphilis.

In Canada, the use of condoms has significantly increased in adolescents due to easy availability and convenience. According to the survey conducted Condom use in penile-vaginal intercourse among Canadian adults: Results from the sex, in 2020, about 30% of studied adult population said they used a condom the everytime when they had sex. Thus, effective protection from sexually transmitted infections and high demand from the young population to enhance their sexual experience is expected to aid the product demand.

Competitive Landscape
The market is moderately competitive in nature. Some of the key industry contributors are AbbVie Inc. (Allergan), Bayer Healthcare, Cooper Surgical Inc. and Mylan Laboratories among others. Companies are undertaking strategic initiatives such as increasing investment in R&D of innovative products to gain a competitive edge from generic products available in the market.